Sarepta Therapeutics (SRPT) Q1 2023 Earnings Call Transcript

SRPT earnings call for the period ending March 31, 2023.

Related Keywords

Maryland ,United States ,Kristen Kluska Cantor Fitzgerald ,Danielle Brill ,Judah Frommer ,Doug Ingram ,Brian Skorney ,Hartaj Singh ,Ian Estepan ,Anupam Rama ,Gena Wang Barclays ,Joseph Schwartz ,Salveen Richter Goldman Sachs ,Shu Zhiqiang Berenberg ,William Blair ,Kristen Kluska ,Tim Lugo William Blair ,Gavin Clark Gartner ,Peter Marks ,Hartaj Singh Oppenheimer ,Mary Jenkins ,Gil Blum ,Colin Bristow ,Brian Abrahams ,Debjit Chattopadhyay Guggenheim ,Danielle Brill Raymond James ,Zhi Shu ,Raymond James ,Anupam Rama Jpmorgan ,Morgan Stanley ,Neena Bitritto Garg ,Debjit Chattopadhyay ,Tazeen Ahmad ,Gil Blum Needham ,America Merrill Lynch ,Gena Wang ,Louise Rodino Klapac ,Tim Lugo ,Goldman Sachs ,Credit Suisse ,Exchange Commission ,Company Analyst ,Cantor Fitzgerald ,Tazeen Ahmad Bank ,Cigna ,Barclays ,Thermo Fisher ,Sarepta Therapeutics ,Dallan Murray ,Motley Fool Stock Advisor ,Stock Advisor ,Sarepta Therapeutic ,Chief Scientific Officer ,Vice President ,Chief Scientific ,North Star Ambulatory Assessment ,Chief Commercial ,Mike Ulz ,Capital Markets ,Ritu Baral ,Guggenheim Partners ,Berenberg Capital Markets ,